Human PRKACa ELISA Kit Drug Target Proteins Patients with metastatic colorectal cancer

Patients with metastatic colorectal cancer that expresses EGFR may be treated with cetuximab in combination with chemotherapy or cetuximab may be given as a single therapy to patients who have failed to respond to irinotecan- and oxaliplatin-based regimens

in LIGHT-induced tumor cell death and chemokine production

belongs to the Selectin family of cell surface glycoproteins

or ANGPT2)

and HRP enzyme conjugate are sequentially added to microwells pre-coated with a Procollagen I (PCI) capture antibody

Human PRKACa ELISA Kit Drug Target Proteins Patients with metastatic colorectal cancerProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and